Diacylglycerol kinase α inhibition cooperates with PD-1-targeted therapies to restore the T cell activation program.
Saved in:
| Title: | Diacylglycerol kinase α inhibition cooperates with PD-1-targeted therapies to restore the T cell activation program. |
|---|---|
| Authors: | Arranz-Nicolás J; Immunology and Oncology, Centro Nacional de Biotecnología-CSIC, Madrid, Spain. jarranz@cnb.csic.es., Martin-Salgado M; Immunology and Oncology, Centro Nacional de Biotecnología-CSIC, Madrid, Spain., Adán-Barrientos I; Immunology and Oncology, Centro Nacional de Biotecnología-CSIC, Madrid, Spain., Liébana R; Immunology and Oncology, Centro Nacional de Biotecnología-CSIC, Madrid, Spain., Del Carmen Moreno-Ortíz M; Immunology and Oncology, Centro Nacional de Biotecnología-CSIC, Madrid, Spain., Leitner J; Center for Pathophysiology, Institute of Immunology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria., Steinberger P; Center for Pathophysiology, Institute of Immunology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria., Ávila-Flores A; Immunology and Oncology, Centro Nacional de Biotecnología-CSIC, Madrid, Spain., Merida I; Immunology and Oncology, Centro Nacional de Biotecnología-CSIC, Madrid, Spain. imerida@cnb.csic.es. |
| Source: | Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2021 Nov; Vol. 70 (11), pp. 3277-3289. Date of Electronic Publication: 2021 Apr 10. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
